Man Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Man Group’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-107,912	Closed	-$14.2M	–	2091
2020 Q4	$14.2M	Buy	+107,912	New	+$9.54M	0.06%	318

Man Group's EIDX Position: Q1 2021 in Review

Man Group sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 107,912 shares — an estimated $14.2M sold.

Man Group first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $14.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Man Group reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Man Group sold 107,912 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $14.2M.
Man Group first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Man Group's Eidos Therapeutics, Inc. Common Stock position peaked at $14.2M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.